Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxysterol-binding protein-like 3 (OSBPL3) is a member of the oxysterol-binding protein family that functions as an intracellular lipid receptor and lipid transfer protein[1][3][7]. OSBPL3 contains an N-terminal pleckstrin homology (PH) domain and a highly conserved C-terminal OSBP-like sterol-binding domain, enabling it to bind specific phosphoinositides and participate in non-vesicular lipid exchange at membrane contact sites such as between the endoplasmic reticulum and plasma membrane[2][3][5][6]. This protein plays critical roles in regulating cell adhesion, cytoskeleton organization, vesicle trafficking, and cellular lipid metabolism[1][3][7]. Aberrant expression or mutation of OSBPL3 is implicated in diverse human cancers and is associated with tumor growth, metastasis, prognosis, and immune microenvironment modulation[1][3]. OSBPL3 is broadly expressed across human tissues, with the highest physiological expression in the parathyroid gland[1]. No approved drugs specifically target OSBPL3, but it is considered a potential therapeutic and prognostic target in oncology and metabolic diseases[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxysterol-binding protein-like 3 (OSBPL3).